COVID-19或流感相关ARDS患者肺组织疱疹病毒存在的组织学证据
该回顾性尸检队列纳入2009至2021年间在ICU死亡并接受尸检的COVID-19相关ARDS(22例)和流感相关ARDS(20例)患者,对肺组织块系统进行HSV-1和CMV的PCR及免疫组化检测。组织学证实HSV-1相关坏死性气管支气管炎见于6/42例(14%),CMV感染仅1例见局灶少量感染细胞。BALF中HSV-1 PCR以4.11 log₁₀ copies/mL为最佳截断值诊断组织学证实的HSV-1感染,敏感度100%、特异度69%。结论认为肺HSV-1以病毒载量依赖方式与部分患者气管支气管炎相关,而肺CMV在组织学上似乎不显著,可能为危重症旁观现象。
要点
- COVID-19或流感相关ARDS死亡患者中,组织学证实的HSV-1相关坏死性气管支气管炎占6/42(14%)。
- BALF HSV-1 PCR最佳截断值4.11 log₁₀ copies/mL诊断组织学证实的HSV-1感染:敏感度100%、特异度69%。
- 组织学证实的CMV感染仅1例,表现为局灶少量CMV感染细胞,作者认为可能为危重症旁观现象。
- 肺HSV-1与气管支气管炎的相关呈病毒载量依赖方式。
适用人群与场景
- 2009至2021年间在ICU死亡并接受尸检的COVID-19相关ARDS(22例)或流感相关ARDS(20例)患者。
诊断标准与关键阈值
- BALF HSV-1 PCR诊断组织学证实的HSV-1感染的最佳截断值为4.11 log₁₀ copies/mL,敏感度100%、特异度69%。
研究设计与关键结果
- 回顾性尸检队列纳入42例患者(COVID-19相关ARDS 22例,流感相关ARDS 20例),对肺组织块系统行HSV-1和CMV的PCR及免疫组化检测。
- 组织学证实的HSV-1相关坏死性气管支气管炎见于6/42例(14%)。
- 组织学证实的CMV感染仅1例,显示局灶少量CMV感染细胞。
- BALF HSV-1 PCR以4.11 log₁₀ copies/mL为截断值诊断组织学证实的HSV-1感染,敏感度100%、特异度69%。
- 肺HSV-1与气管支气管炎的相关呈病毒载量依赖方式;肺CMV在组织学上似乎不显著,可能为危重症旁观现象。
证据类型、等级与局限
- 证据类型:回顾性尸检队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肺HSV-1以病毒载量依赖方式与部分COVID-19或流感相关ARDS患者的气管支气管炎相关。
- 作者认为,肺CMV存在在组织学上似乎不显著,可能代表危重症的旁观现象。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Herpes simplex virus type 1 (HSV-1) and cytomegalovirus (CMV) are frequently detected in respiratory samples from patients with acute respiratory distress syndrome (ARDS), yet whether PCR positivity reflects histologically confirmed pulmonary infection and contributes to lung injury remains unclear. We aimed to characterize the histopathological features of pulmonary HSV-1 and CMV using PCR and immunohistochemistry on lung tissue specimens of critically ill patients with influenza- or COVID-19-related ARDS obtained at autopsy. In addition, we sought to correlate pulmonary herpesvirus loads in antemortem bronchoalveolar lavage fluid (BALF) samples with postmortem histological findings. METHODS: In this retrospective autopsy cohort, we included patients with COVID-19- or influenza-related ARDS who died in the intensive care unit and underwent autopsy between 2009 and 2021. Lung tissue blocks were systematically screened for HSV-1 and CMV using PCR and immunohistochemistry. Performance of HSV-1 PCR on BALF for diagnosing proven HSV-1 infection was evaluated with receiver operating characteristic analysis. RESULTS: We included 22 patients with COVID-19- and 20 with influenza-related ARDS. Proven HSV-1-associated necrotizing tracheobronchitis was identified in 6/42 patients (14%). Proven CMV infection was identified in only one patient, displaying focal presence of a few CMV-infected cells. An optimal cutoff of 4.11 log₁₀ copies/mL for HSV-1 in BALF yielded 100% sensitivity and 69% specificity for diagnosis of proven HSV-1 infection. CONCLUSIONS: Pulmonary HSV-1 was associated with tracheobronchitis in a subset of patients in a viral load dependent manner. Pulmonary CMV presence appeared histologically insignificant and likely represents a bystander phenomenon of critical illness.
参考来源
- Heylen J, Lopuhaä B, Vanderbeke L, et al. Histological proof of pulmonary herpesvirus presence in patients with COVID-19- or influenza-related ARDS. Crit Care. 2026. PMID: 41928312. doi:10.1186/s13054-026-05988-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。